Back to search
FDAFDA · Food and drugs·Recall number D-713-2014

BENAZEPRIL HCL Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162075410

Published January 22, 2014 · Recall initiated: July 2, 2013

Summary

FDA records drug Class II recall D-713-2014, published January 22, 2014 and initiated July 2, 2013. Recalling firm: Aidapak Services, LLC; Status: Terminated; Reported quantity: 799 Tablets; Lot: BENAZEPRIL HCL Tablet, 40 mg has the following codes Pedigree: AD49423_1, EXP: 5/16/2014; Pedigree: W003918, EXP: 6/28/2014; Pedigree: AD32757_7, EXP: 5/13/2014; Pedigree: AD68010_1, EXP: 5/28/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 40 mg may be potentially mislabeled as NEFAZODONE HCL, Tablet, 200 mg, NDC 00093102506, Pedigree: AD46414_44, EXP: 5/16/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003931, EXP: 6/28/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD42592_1, EXP: 5/14/2014; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/25

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aidapak Services, LLC
Distributor
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Lot
BENAZEPRIL HCL Tablet, 40 mg has the following codes Pedigree: AD49423_1, EXP: 5/16/2014; Pedigree: W003918, EXP: 6/28/2014; Pedigree: AD32757_7, EXP: 5/13/2014; Pedigree: AD68010_1, EXP: 5/28/2014.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BENAZEPRIL HCL Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162075410 recalled?

Yes. FDA published recall D-713-2014 on January 22, 2014. Reported hazard: Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 40 mg may be potentially mislabeled as NEFAZODONE HCL, Tablet, 200 mg, NDC 00093102506, Pedigree: AD46414_44, EXP: 5/16/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003931, EXP: 6/28/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD42592_1, EXP: 5/14/2014; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/25

What should I do if I have this product?

Voluntary: Firm initiated · Telephone